Letters
SSRIs and tamoxifen
Authors’ reply
BMJ 2010; 340 doi: https://doi.org/10.1136/bmj.c1321 (Published 10 March 2010) Cite this as: BMJ 2010;340:c1321
- Frank Andersohn, senior research associate1,
- Stefan N Willich, professor and director1
- 1Institute for Social Medicine, Epidemiology, and Health Economics, Charité University Medical Centre, 10098 Berlin, Germany
- frank.andersohn{at}charite.de
Our recommendations and those of others (full reference details of which are available in the response on bmj.com) to avoid coprescribing fluoxetine and tamoxifen are not based on a hypothesis alone, as indicated by Jenkinson,1 2 but on the growing evidence of a central role for cytochrome P450 2D6 …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.